Will Weakness in Edwards Lifesciences Corporation's (NYSE:EW) Stock Prove Temporary Given Strong Fundamentals?
It is hard to get excited after looking at Edwards Lifesciences' (NYSE:EW) recent performance, when its stock has declined 7.9% over the past three months. But if you pay close attention, you might
Express News | Watching AtriCure; Traders Circulating Unconfirmed Rumor Suggesting Edwards Lifesciences Is Said To Mull Takeover Bid For The Co
AtriCure Gains Amid Report of Edwards Lifesciences Interest
Wolfe Research Adjusts Price Target on Edwards Lifesciences to $70 From $75
Edwards Lifesciences (EW) has an average rating of outperform and price targets ranging from $70 to $107, according to analysts polled by eCapital IQ. Price: 86.40, Change: -0.89, Percent Change: -1.0
Edwards Lifesciences(EW.US) Officer Sells US$437.7K in Common Stock
$Edwards Lifesciences(EW.US)$ Officer BOBO DONALD E JR sold 5,000 shares of common stock on Jun 12, 2024 at an average price of $87.5393 for a total value of $437.7K.Source: Announcement What is state
Form 144 | Edwards Lifesciences(EW.US) Insider Proposes to Sell 8.03 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 11, $Edwards Lifesciences(EW.US)$ Insider Michael A. Mussallem intends to sell 92,300 shares of its common stock on Jun 11, with a total market value of approximately $8.03
HOLX Vs. EW: Which Stock Should Value Investors Buy Now?
Investors looking for stocks in the Medical - Instruments sector might want to consider either Hologic (HOLX) or Edwards Lifesciences (EW).
Jefferies Maintains Edwards Lifesciences(EW.US) With Buy Rating, Maintains Target Price $102
Jefferies analyst Matthew Taylor maintains $Edwards Lifesciences(EW.US)$ with a buy rating, and maintains the target price at $102.According to TipRanks data, the analyst has a success rate of 60.3% a
TD Cowen Maintains Edwards Lifesciences(EW.US) With Buy Rating, Maintains Target Price $100
TD Cowen analyst Josh Jennings maintains $Edwards Lifesciences(EW.US)$ with a buy rating, and maintains the target price at $100.According to TipRanks data, the analyst has a success rate of 52.4% and
Express News | NYSE Order Imbalance 65222.0 Shares on Sell Side
Edwards Lifesciences Presents 5-Year Follow Up Data From PARTNER Trials Showing Clinical Outcomes For Female And Small Annulus Patients With Transcatheter Aortic Valve Replacement At The New York Valves 2024: The Structural Heart Summit
Edwards Lifesciences (NYSE:EW) today announced the results from an analysis of data from the PARTNER Trials examining outcomes of transcatheter aortic valve replacement (TAVR) patients with a small an
The Most Crowded Longs and Shorts in U.S. Med-Tech for May - UBS
Edwards Lifesciences (NYSE:EW) Has A Pretty Healthy Balance Sheet
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the permanent loss of capital.' So it might be obvious that you need to consider debt, whe
Five-Year Data Show Excellent Outcomes for Female and Small Annulus Patients With Edwards TAVR
NEW YORK--(BUSINESS WIRE)-- Edwards Lifesciences (NYSE: EW) today announced the results from an analysis of data from the PARTNER Trials examining outcomes of transcatheter aortic valve replacement (
Edwards Lifesciences Deal A Clear Win For Becton Dickinson, Analysts Say -- Analysis
By Denny Jacob Becton Dickinson stands to get a bigger strategic boost from its $4.2 billion acquisition of Edwards Lifesciences' critical care unit, according to some analysts, who otherwise view th
A Quick Look at Today's Ratings for Edwards Lifesciences(EW.US), With a Forecast Between $85 to $101
On Jun 04, major Wall Street analysts update their ratings for $Edwards Lifesciences(EW.US)$, with price targets ranging from $85 to $101.Barclays analyst Matt Miksic maintains with a buy rating, and
Edwards Lifesciences (NYSE:EW) Knows How To Allocate Capital
BD to Acquire Edwards Lifesciences' Critical Care Unit for $4.2bn
Express News | Edwards Lifesciences Corp : Goldman Sachs Adds Stock to Its US Conviction List
News Highlights: Top Company News of the Day - Monday at 7 PM ET
E*Trade Considers Kicking Meme-Stock Leader Keith Gill Off Platform Morgan Stanley's trading platform discusses concerns about possible manipulation in GameStop. Spotify Shares Jump on Price Hikes
No Data